Xonvea

Xonvea is a prescription medication specifically developed to manage nausea and vomiting in pregnancy (NVP). It is indicated for use when symptoms persist despite non-pharmacological measures such as dietary modification, eating small frequent meals, staying well hydrated, and avoiding known triggers. When these measures are insufficient and symptoms begin to affect daily functioning and nutritional intake, Xonvea provides a targeted pharmacological option with an established safety profile in pregnancy.

The medication contains two active ingredients that work in a complementary way. Doxylamine succinate is a sedating antihistamine that acts on histamine H1 receptors in the brain, reducing the neurological signals that trigger nausea and vomiting. Pyridoxine hydrochloride is the active form of vitamin B6, which has been shown to reduce pregnancy-related nausea through its role in neurotransmitter regulation. Together, these two ingredients target nausea through more than one physiological pathway, which may improve effectiveness compared with single-ingredient approaches.

Xonvea is the only prescription medicine licensed in the UK specifically for nausea and vomiting in pregnancy, providing a treatment option with a clearly defined indication and well-understood safety profile in pregnant women.

Its dual-action formulation targeting nausea through complementary mechanisms means it may offer superior symptom control to single-ingredient treatments for many women. By reducing persistent nausea and vomiting, Xonvea helps pregnant women maintain adequate nutrition and hydration, continue with normal daily activities, and reduce the physical and emotional burden that moderate to severe morning sickness can cause. The active ingredients have an established record of use in pregnant populations, supporting their use when symptoms require medical management.

Xonvea is a delayed-release tablet and must be swallowed whole. Do not crush, split, or chew the tablets as this affects how the medication is released and absorbed.

Your prescribing clinician will advise on the specific dosing regimen most appropriate for your symptoms and stage of pregnancy. Treatment typically begins with one or two tablets taken at bedtime, with the dose adjusted according to symptom response and tolerability. Because doxylamine is sedating, Xonvea is generally prescribed for evening use to minimise daytime drowsiness.

Do not take more than the prescribed dose. Follow the instructions provided at the time of your consultation carefully, and do not adjust your dosing without speaking to your prescriber first.

Because doxylamine is a sedating antihistamine, drowsiness is the most commonly reported side effect of Xonvea. This is a predictable pharmacological effect of the active ingredient and is why the medication is generally taken at bedtime.

Common side effects include drowsiness or fatigue, dry mouth, dizziness, and constipation.

Less common side effects include confusion, restlessness, and palpitations, particularly if the medication is not taken as directed or is combined with alcohol or other sedating substances.

Due to its sedating effects, you should not drive, operate heavy machinery, or perform tasks requiring full alertness until you know how Xonvea affects you. Avoid alcohol and any other medications that cause drowsiness while taking Xonvea, as the combination significantly increases sedative effects.

If you experience any persistent or concerning side effects, contact your prescribing clinician, midwife, or GP promptly.

• Conditions requiring caution: Xonvea should be used with particular care in women who are sensitive to sedating medications, have respiratory conditions such as asthma, have narrow-angle glaucoma, experience digestive obstruction or peptic ulcers, or have urinary retention or bladder difficulties. Inform your prescribing clinician of any of these conditions during your consultation.
• Alcohol and sedating medications: Do not consume alcohol or take other medications with sedating properties while using Xonvea. The combination with doxylamine can significantly increase drowsiness and impair your ability to function safely.
• Do not use Xonvea if you: have a known allergy to doxylamine, pyridoxine, or any related antihistamines; are currently taking or have recently taken monoamine oxidase inhibitors (MAOIs); or have a known hypersensitivity to any of the ingredients in the formulation.
• Driving: Do not drive or operate machinery if you feel sedated after taking Xonvea. Doxylamine impairs concentration and reaction time and this effect may persist into the following day in some women.
• Disclosure of all medications: Always inform your prescribing clinician about every medication you are currently taking, including prescription drugs, over-the-counter products, vitamins, and supplements, before starting Xonvea. This allows your prescriber to identify any potential interactions.

Xonvea is typically prescribed when nausea and vomiting during pregnancy persist despite dietary and lifestyle adjustments, when symptoms are significantly interfering with daily activities, nutritional intake, or hydration, or when other management approaches are not suitable or have not been effective. It may form part of a broader treatment plan depending on the severity of symptoms, and the dose may be adjusted over the course of pregnancy as your symptoms change.

For women experiencing very severe vomiting in pregnancy, a condition known as hyperemesis gravidarum, additional clinical assessment will be required. This condition may necessitate referral to a specialist or hospital admission for intravenous fluids and more intensive management. If your symptoms are severe, persistent, or if you are losing weight or are unable to keep any fluids down, contact your GP or midwife promptly rather than relying on Xonvea alone.

• What is Xonvea used for? Xonvea is a prescription tablet used to treat nausea and vomiting during pregnancy, commonly known as morning sickness. It is the only medicine licensed in the UK specifically for this indication and is recommended when dietary and lifestyle measures have not provided sufficient relief and symptoms are affecting daily functioning.
• What does Xonvea contain? Xonvea contains doxylamine succinate, a sedating antihistamine that reduces nausea signals in the brain, and pyridoxine hydrochloride (vitamin B6), which plays a role in reducing pregnancy-related nausea. These two ingredients work through complementary mechanisms to control symptoms more effectively than either alone.
• Is Xonvea safe to take during pregnancy? Xonvea is the only prescription medicine licensed in the UK specifically for nausea and vomiting in pregnancy. It is prescribed when the clinical benefits of controlling symptoms outweigh any potential risks and when non-medical approaches have been insufficient. The active ingredients have an established record of use in pregnant populations. It should be taken exactly as prescribed and under ongoing healthcare supervision.
• Can I buy Xonvea online in the UK? Yes. Xonvea is available from My London Pharmacy following a short online consultation reviewed by our UK-registered prescribing pharmacist. The prescription is included with no consultation charges and no GP appointment is required. Free tracked delivery in plain packaging is provided.
• What are the side effects of Xonvea? The most common side effect is drowsiness, which is why Xonvea is generally taken at bedtime. Other common side effects include dry mouth, dizziness, and constipation. Less common effects include confusion and palpitations. Avoid alcohol and other sedating medications while taking Xonvea as these significantly increase drowsiness.
• Can I drive while taking Xonvea? You should not drive or operate machinery if you feel drowsy after taking Xonvea. Doxylamine is a sedating antihistamine and can impair concentration and reaction time. This effect may persist into the following morning. Take particular care until you know how Xonvea affects you.
• Are there any medications I cannot take with Xonvea? Xonvea must not be taken alongside MAOIs (monoamine oxidase inhibitors). It should not be combined with alcohol or other sedating medications. Always disclose all current medications during your consultation so your prescribing clinician can check for any interactions.
• Who should not take Xonvea? Xonvea is not suitable for women with a known allergy to doxylamine, pyridoxine, or related antihistamines, those currently taking MAOIs, or those with hypersensitivity to any of the ingredients. Women with narrow-angle glaucoma, urinary retention, certain gastrointestinal conditions, respiratory conditions such as asthma, or high sensitivity to sedating medications should discuss their suitability with their prescribing clinician before use.
• What if my symptoms are very severe? Xonvea is appropriate for moderate nausea and vomiting in pregnancy that has not responded to lifestyle measures. For severe or persistent vomiting, significant weight loss, or inability to keep fluids down, a condition known as hyperemesis gravidarum may be present. This requires prompt assessment by your GP or midwife and may require hospital treatment including intravenous fluids. Do not rely on Xonvea alone if your symptoms are severe.
• How long will I need to take Xonvea? The duration of treatment depends on how your symptoms progress throughout pregnancy. For most women, nausea and vomiting in pregnancy improves after the first trimester. Your prescribing clinician will review your treatment regularly and advise when it is appropriate to reduce or stop the medication.